182 related articles for article (PubMed ID: 15613445)
21. Improved tumor targeting by combined use of two antitenascin antibodies.
Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
[TBL] [Abstract][Full Text] [Related]
22. Advances in cancer: antibody targeting of cancer--prospects for detection and therapy.
Goldenberg DM
N J Med; 1987 Mar; 84(3):195-8. PubMed ID: 3550534
[No Abstract] [Full Text] [Related]
23. Possible applications of antibodies or their genes in cancer therapy.
Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
[TBL] [Abstract][Full Text] [Related]
24. Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphoma.
Martin P; Furman RR; Ruan J; Elstrom R; Barrientos J; Niesvizky R; Coleman M; Leonard JP
Semin Hematol; 2008 Apr; 45(2):126-32. PubMed ID: 18381108
[TBL] [Abstract][Full Text] [Related]
25. MHC class I-related chain A conjugated to antitumor antibodies can sensitize tumor cells to specific lysis by natural killer cells.
Germain C; Larbouret C; Cesson V; Donda A; Held W; Mach JP; Pèlegrin A; Robert B
Clin Cancer Res; 2005 Oct; 11(20):7516-22. PubMed ID: 16243826
[TBL] [Abstract][Full Text] [Related]
26. Tumor-associated antigens and biomarkers in cancer and immune therapy.
Malyankar UM
Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
[TBL] [Abstract][Full Text] [Related]
27. Novel antibodies as anticancer agents.
Zafir-Lavie I; Michaeli Y; Reiter Y
Oncogene; 2007 May; 26(25):3714-33. PubMed ID: 17530025
[TBL] [Abstract][Full Text] [Related]
28. Antibody-guided radiation therapy of cancer.
Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
[TBL] [Abstract][Full Text] [Related]
29. Antibody-directed enzyme prodrug therapy (ADEPT) for cancer.
Bagshawe KD
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1421-31. PubMed ID: 17069527
[TBL] [Abstract][Full Text] [Related]
30. Novel radiolabeled antibody conjugates.
Goldenberg DM; Sharkey RM
Oncogene; 2007 May; 26(25):3734-44. PubMed ID: 17530026
[TBL] [Abstract][Full Text] [Related]
31. Tumor antigens as surrogate markers and targets for therapy and vaccines.
Dalgleish A; Pandha H
Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680
[TBL] [Abstract][Full Text] [Related]
32. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.
Gnjatic S; Wheeler C; Ebner M; Ritter E; Murray A; Altorki NK; Ferrara CA; Hepburne-Scott H; Joyce S; Koopman J; McAndrew MB; Workman N; Ritter G; Fallon R; Old LJ
J Immunol Methods; 2009 Feb; 341(1-2):50-8. PubMed ID: 19041653
[TBL] [Abstract][Full Text] [Related]
33. Identification and distribution of thioredoxin-like 2 as the antigen for the monoclonal antibody MC3 specific to colorectal cancer.
Lu Y; Wang X; Liu Z; Jin B; Chu D; Zhai H; Zhang F; Li K; Ren G; Miranda-Vizuete A; Guo X; Fan D
Proteomics; 2008 Jun; 8(11):2220-9. PubMed ID: 18528843
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody CC188 binds a carbohydrate epitope expressed on the surface of both colorectal cancer stem cells and their differentiated progeny.
Xu M; Yuan Y; Xia Y; Achilefu S
Clin Cancer Res; 2008 Nov; 14(22):7461-9. PubMed ID: 19010863
[TBL] [Abstract][Full Text] [Related]
35. Antibodies and vaccines--hope or illusion?
Jäger D; Knuth A
Breast; 2005 Dec; 14(6):631-5. PubMed ID: 16242931
[TBL] [Abstract][Full Text] [Related]
36. Engineered affinity proteins for tumour-targeting applications.
Friedman M; Ståhl S
Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363
[TBL] [Abstract][Full Text] [Related]
37. Human tumor cell lysates as a protein source for the detection of cancer antigen-specific humoral immunity.
Goodell V; Disis ML
J Immunol Methods; 2005 Apr; 299(1-2):129-38. PubMed ID: 15914197
[TBL] [Abstract][Full Text] [Related]
38. Autologous antibodies to meningioma cell surface antigens.
Pfreundschuh M; Röhrich M; Piotrowksi W; Penzholz H; Fischer H
Anticancer Res; 1981; 1(6):367-72. PubMed ID: 6284017
[TBL] [Abstract][Full Text] [Related]
39. B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
Liu A; Hu P; Khawli LA; Epstein AL
J Immunother; 2006; 29(4):425-35. PubMed ID: 16799338
[TBL] [Abstract][Full Text] [Related]
40. Detection of humoral antibody response to polyoma tumor-specific cell-surface antigen.
Ting CC; Herberman RB
J Natl Cancer Inst; 1970 Mar; 44(3):729-37. PubMed ID: 11515441
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
